Date Filed | Type | Description |
10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2023 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns:
| Granted 259 options to buy
@ $149.06, valued at
$38.6k
|
|
07/13/2023 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on Xos, Inc.
Txns:
| Granted 15,151 shares
@ $0 |
|
07/05/2023 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns:
| Granted 287 options to buy
@ $134.73, valued at
$38.7k
|
|
05/09/2023 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns:
| Granted 1,450 shares
@ $0 |
|
04/04/2023 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns:
| Granted 243 options to buy
@ $159.37, valued at
$38.7k
|
|
04/04/2023 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on Xos, Inc.
Txns:
| Granted 7,936 shares
@ $0 |
|
01/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/04/2022 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns:
| Granted 288 options to buy
@ $134.21, valued at
$38.7k
|
|
10/04/2022 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on Xos, Inc.
Txns:
| Granted 3,378 shares
@ $0 |
|
09/14/2022 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on Xos, Inc.
Txns:
| Granted 115,606 shares
@ $0 |
|
08/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/05/2022 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns:
| Granted 237 options to buy
@ $153.16, valued at
$36.3k
|
|
05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/04/2022 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns:
| Granted 217 options to buy
@ $162.11, valued at
$35.2k
|
|
02/14/2022 |
5
| RAPP EDWARD J (Director) has filed a Form 5 on Xos, Inc. |
01/04/2022 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns:
| Granted 260 options to buy
@ $135.4, valued at
$35.2k
|
|
01/04/2022 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on Xos, Inc.
Txns:
| Granted 1,474 shares
@ $0 |
|
11/22/2021 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on Xos, Inc.
Txns:
| Bought 100,000 shares
@ $4.2682, valued at
$426.8k
|
|
11/15/2021 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on Xos, Inc.
Txns:
| Granted 57,229 restricted stock units
@ $0 Granted 31,794 restricted stock units
@ $0 |
|
10/04/2021 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns:
| Granted 326 options to buy
@ $107.87, valued at
$35.2k
|
|
09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/02/2021 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns:
| Granted 312 options to buy
@ $112.67, valued at
$35.2k
|
|
05/11/2021 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns:
| Granted 1,681 shares
@ $0 |
|
04/01/2021 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns:
| Granted 325 options to buy
@ $108.22, valued at
$35.2k
|
|
01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2020 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns:
| Granted 350 options to buy
@ $98.18, valued at
$34.4k
|
|
05/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/02/2020 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns:
| Granted 446 options to buy
@ $0 |
|
|